Search: projects

Country:
Field of expertise:
Assignment:
Client:
Description:
Order by:

Assignment:	Regional assessment of Patent and Intellectual Property issues and Access to Medicines
Client:	CARICOM (Caribbean Community Secretariat
Country:	Dominica
Fields of expertise:	Access to Medicine Campaigns, Appraisal, Drug Regulatory Authority Support, National Medicines Policy Development
Description:	Narrative Description of Project: The general objectives of the Assessment were: To explore the possibilities of developing a harmonized, pro-public health regional (Caribbean) IP regulation and drug policy (to include generic drugs) framework To make recommendations on the IP/patent legislation and regulations that will maximize TRIPS flexibilities while being TRIPS compliant To identify the requirements and process for establishing a regional negotiating platform for drugs To identify mechanisms for building/strengthening coalitions and negotiating positions at the WTO, and in bilateral and regional fora for ensuring access to drugs To make recommendations on the adequacy of the systems in Member States for regulation of the pharmaceutical market to ensure the timely supply of safe, effective and quality medicines. Description of Actual Services Provided: Development of a work plan i consultation with the Technical Advisory Group (TAG) and PANCAP Thorough review of all available literature/documents and prior regional studies pertaining to patent legislation, regulations and decrees that focus, in particular, on TRIPS compliance, TRIPS flexibilities; TRIPS + Provisions, and other general issues relating to patent systems; Data collection, analysis of processes and systems that have been adopted in implementing TRIPS flexibilities, TRIPS+ Provisions, at the practical level in the region and provision of a qualitative assessment of the data collected Recommendations and proposal of strategies for addressing needs and gaps identified at national levels and the establishment of a regional platform for future trade negotiations relating to access to medicines and other pharmaceuticals in the context of the Caribbean Single Market and economy. Development of the data collection instrument Test and modification of the data collation instrument in 2 Member States- one that has a well developed IP system and one with a rudimentary system. Trinidad and Tobago and Guyana; Interviews with the relevant persons and agencies at the country and regional level
Year:	2008 - 2009

Assignment:	Regional assessment of Patent and Intellectual Property issues and Access to Medicines
Client:	CARICOM (Caribbean Community Secretariat
Country:	Dominican Republic
Fields of expertise:	Access to Medicine Campaigns, Appraisal, Drug Regulatory Authority Support, National Medicines Policy Development
Description:	Narrative Description of Project: The general objectives of the Assessment were: To explore the possibilities of developing a harmonized, pro-public health regional (Caribbean) IP regulation and drug policy (to include generic drugs) framework To make recommendations on the IP/patent legislation and regulations that will maximize TRIPS flexibilities while being TRIPS compliant To identify the requirements and process for establishing a regional negotiating platform for drugs To identify mechanisms for building/strengthening coalitions and negotiating positions at the WTO, and in bilateral and regional fora for ensuring access to drugs To make recommendations on the adequacy of the systems in Member States for regulation of the pharmaceutical market to ensure the timely supply of safe, effective and quality medicines. Description of Actual Services Provided: Development of a work plan i consultation with the Technical Advisory Group (TAG) and PANCAP Thorough review of all available literature/documents and prior regional studies pertaining to patent legislation, regulations and decrees that focus, in particular, on TRIPS compliance, TRIPS flexibilities; TRIPS + Provisions, and other general issues relating to patent systems; Data collection, analysis of processes and systems that have been adopted in implementing TRIPS flexibilities, TRIPS+ Provisions, at the practical level in the region and provision of a qualitative assessment of the data collected Recommendations and proposal of strategies for addressing needs and gaps identified at national levels and the establishment of a regional platform for future trade negotiations relating to access to medicines and other pharmaceuticals in the context of the Caribbean Single Market and economy. Development of the data collection instrument Test and modification of the data collation instrument in 2 Member States- one that has a well developed IP system and one with a rudimentary system. Trinidad and Tobago and Guyana; Interviews with the relevant persons and agencies at the country and regional level
Year:	2008 - 2009

Assignment:	Regional assessment of Patent and Intellectual Property issues and Access to Medicines
Client:	Caricom (Caribbean Community Secretariat)
Country:	Barbados
Fields of expertise:	Access to Medicine Campaigns, Appraisal, Drug Regulatory Authority Support, National Medicines Policy Development
Description:	Narrative Description of Project: The general objectives of the Assessment were: To explore the possibilities of developing a harmonized, pro-public health regional (Caribbean) IP regulation and drug policy (to include generic drugs) framework To make recommendations on the IP/patent legislation and regulations that will maximize TRIPS flexibilities while being TRIPS compliant To identify the requirements and process for establishing a regional negotiating platform for drugs To identify mechanisms for building/strengthening coalitions and negotiating positions at the WTO, and in bilateral and regional fora for ensuring access to drugs To make recommendations on the adequacy of the systems in Member States for regulation of the pharmaceutical market to ensure the timely supply of safe, effective and quality medicines. Description of Actual Services Provided: Development of a work plan i consultation with the Technical Advisory Group (TAG) and PANCAP Thorough review of all available literature/documents and prior regional studies pertaining to patent legislation, regulations and decrees that focus, in particular, on TRIPS compliance, TRIPS flexibilities; TRIPS + Provisions, and other general issues relating to patent systems; Data collection, analysis of processes and systems that have been adopted in implementing TRIPS flexibilities, TRIPS+ Provisions, at the practical level in the region and provision of a qualitative assessment of the data collected Recommendations and proposal of strategies for addressing needs and gaps identified at national levels and the establishment of a regional platform for future trade negotiations relating to access to medicines and other pharmaceuticals in the context of the Caribbean Single Market and economy. Development of the data collection instrument Test and modification of the data collation instrument in 2 Member States- one that has a well developed IP system and one with a rudimentary system. Trinidad and Tobago and Guyana; Interviews with the relevant persons and agencies at the country and regional level
Year:	2008 - 2009

Assignment:	Regional assessment of Patent and Intellectual Property issues and Access to Medicines
Client:	CARICOM (Caribbean Community Secretariat)
Country:	Antigua and Barbuda
Fields of expertise:	Access to Medicine Campaigns, Appraisal, Drug Regulatory Authority Support, National Medicines Policy Development
Description:	Narrative Description of Project: The general objectives of the Assessment were: To explore the possibilities of developing a harmonized, pro-public health regional (Caribbean) IP regulation and drug policy (to include generic drugs) framework To make recommendations on the IP/patent legislation and regulations that will maximize TRIPS flexibilities while being TRIPS compliant To identify the requirements and process for establishing a regional negotiating platform for drugs To identify mechanisms for building/strengthening coalitions and negotiating positions at the WTO, and in bilateral and regional fora for ensuring access to drugs To make recommendations on the adequacy of the systems in Member States for regulation of the pharmaceutical market to ensure the timely supply of safe, effective and quality medicines. Description of Actual Services Provided: Development of a work plan i consultation with the Technical Advisory Group (TAG) and PANCAP Thorough review of all available literature/documents and prior regional studies pertaining to patent legislation, regulations and decrees that focus, in particular, on TRIPS compliance, TRIPS flexibilities; TRIPS + Provisions, and other general issues relating to patent systems; Data collection, analysis of processes and systems that have been adopted in implementing TRIPS flexibilities, TRIPS+ Provisions, at the practical level in the region and provision of a qualitative assessment of the data collected Recommendations and proposal of strategies for addressing needs and gaps identified at national levels and the establishment of a regional platform for future trade negotiations relating to access to medicines and other pharmaceuticals in the context of the Caribbean Single Market and economy. Development of the data collection instrument Test and modification of the data collation instrument in 2 Member States- one that has a well developed IP system and one with a rudimentary system. Trinidad and Tobago and Guyana; Interviews with the relevant persons and agencies at the country and regional level
Year:	2008 - 2009

Assignment:	Regional assessment of Patent and Intellectual Property issues and Access to Medicines
Client:	CARICOM (Caribbean Community Secretariat)
Country:	Grenada
Fields of expertise:	Access to Medicine Campaigns, Appraisal, Drug Regulatory Authority Support, National Medicines Policy Development
Description:	Narrative Description of Project: The general objectives of the Assessment were: To explore the possibilities of developing a harmonized, pro-public health regional (Caribbean) IP regulation and drug policy (to include generic drugs) framework To make recommendations on the IP/patent legislation and regulations that will maximize TRIPS flexibilities while being TRIPS compliant To identify the requirements and process for establishing a regional negotiating platform for drugs To identify mechanisms for building/strengthening coalitions and negotiating positions at the WTO, and in bilateral and regional fora for ensuring access to drugs To make recommendations on the adequacy of the systems in Member States for regulation of the pharmaceutical market to ensure the timely supply of safe, effective and quality medicines. Description of Actual Services Provided: Development of a work plan i consultation with the Technical Advisory Group (TAG) and PANCAP Thorough review of all available literature/documents and prior regional studies pertaining to patent legislation, regulations and decrees that focus, in particular, on TRIPS compliance, TRIPS flexibilities; TRIPS + Provisions, and other general issues relating to patent systems; Data collection, analysis of processes and systems that have been adopted in implementing TRIPS flexibilities, TRIPS+ Provisions, at the practical level in the region and provision of a qualitative assessment of the data collected Recommendations and proposal of strategies for addressing needs and gaps identified at national levels and the establishment of a regional platform for future trade negotiations relating to access to medicines and other pharmaceuticals in the context of the Caribbean Single Market and economy. Development of the data collection instrument Test and modification of the data collation instrument in 2 Member States- one that has a well developed IP system and one with a rudimentary system. Trinidad and Tobago and Guyana; Interviews with the relevant persons and agencies at the country and regional level
Year:	2008 - 2009

Assignment:	Regional assessment of Patent and Intellectual Property issues and Access to Medicines
Client:	CARICOM (Caribbean Community Secretariat)
Country:	Guyana
Fields of expertise:	Access to Medicine Campaigns, Appraisal, Drug Regulatory Authority Support, National Medicines Policy Development
Description:	Narrative Description of Project: The general objectives of the Assessment were: To explore the possibilities of developing a harmonized, pro-public health regional (Caribbean) IP regulation and drug policy (to include generic drugs) framework To make recommendations on the IP/patent legislation and regulations that will maximize TRIPS flexibilities while being TRIPS compliant To identify the requirements and process for establishing a regional negotiating platform for drugs To identify mechanisms for building/strengthening coalitions and negotiating positions at the WTO, and in bilateral and regional fora for ensuring access to drugs To make recommendations on the adequacy of the systems in Member States for regulation of the pharmaceutical market to ensure the timely supply of safe, effective and quality medicines. Description of Actual Services Provided: Development of a work plan i consultation with the Technical Advisory Group (TAG) and PANCAP Thorough review of all available literature/documents and prior regional studies pertaining to patent legislation, regulations and decrees that focus, in particular, on TRIPS compliance, TRIPS flexibilities; TRIPS + Provisions, and other general issues relating to patent systems; Data collection, analysis of processes and systems that have been adopted in implementing TRIPS flexibilities, TRIPS+ Provisions, at the practical level in the region and provision of a qualitative assessment of the data collected Recommendations and proposal of strategies for addressing needs and gaps identified at national levels and the establishment of a regional platform for future trade negotiations relating to access to medicines and other pharmaceuticals in the context of the Caribbean Single Market and economy. Development of the data collection instrument Test and modification of the data collation instrument in 2 Member States- one that has a well developed IP system and one with a rudimentary system. Trinidad and Tobago and Guyana; Interviews with the relevant persons and agencies at the country and regional level
Year:	2008 - 2009

Assignment:	Regional assessment of Patent and Intellectual Property issues and Access to Medicines
Client:	CARICOM (Caribbean Community Secretariat)
Country:	Haiti
Fields of expertise:	Access to Medicine Campaigns, Appraisal, Drug Regulatory Authority Support, National Medicines Policy Development
Description:	Narrative Description of Project: The general objectives of the Assessment were: To explore the possibilities of developing a harmonized, pro-public health regional (Caribbean) IP regulation and drug policy (to include generic drugs) framework To make recommendations on the IP/patent legislation and regulations that will maximize TRIPS flexibilities while being TRIPS compliant To identify the requirements and process for establishing a regional negotiating platform for drugs To identify mechanisms for building/strengthening coalitions and negotiating positions at the WTO, and in bilateral and regional fora for ensuring access to drugs To make recommendations on the adequacy of the systems in Member States for regulation of the pharmaceutical market to ensure the timely supply of safe, effective and quality medicines. Description of Actual Services Provided: Development of a work plan i consultation with the Technical Advisory Group (TAG) and PANCAP Thorough review of all available literature/documents and prior regional studies pertaining to patent legislation, regulations and decrees that focus, in particular, on TRIPS compliance, TRIPS flexibilities; TRIPS + Provisions, and other general issues relating to patent systems; Data collection, analysis of processes and systems that have been adopted in implementing TRIPS flexibilities, TRIPS+ Provisions, at the practical level in the region and provision of a qualitative assessment of the data collected Recommendations and proposal of strategies for addressing needs and gaps identified at national levels and the establishment of a regional platform for future trade negotiations relating to access to medicines and other pharmaceuticals in the context of the Caribbean Single Market and economy. Development of the data collection instrument Test and modification of the data collation instrument in 2 Member States- one that has a well developed IP system and one with a rudimentary system. Trinidad and Tobago and Guyana; Interviews with the relevant persons and agencies at the country and regional level
Year:	2008 - 2009

Assignment:	Regional assessment of Patent and Intellectual Property issues and Access to Medicines
Client:	CARICOM (Caribbean Community Secretariat)
Country:	Jamaica
Fields of expertise:	Access to Medicine Campaigns, Appraisal, Drug Regulatory Authority Support, National Medicines Policy Development
Description:	Narrative Description of Project: The general objectives of the Assessment were: To explore the possibilities of developing a harmonized, pro-public health regional (Caribbean) IP regulation and drug policy (to include generic drugs) framework To make recommendations on the IP/patent legislation and regulations that will maximize TRIPS flexibilities while being TRIPS compliant To identify the requirements and process for establishing a regional negotiating platform for drugs To identify mechanisms for building/strengthening coalitions and negotiating positions at the WTO, and in bilateral and regional fora for ensuring access to drugs To make recommendations on the adequacy of the systems in Member States for regulation of the pharmaceutical market to ensure the timely supply of safe, effective and quality medicines. Description of Actual Services Provided: Development of a work plan i consultation with the Technical Advisory Group (TAG) and PANCAP Thorough review of all available literature/documents and prior regional studies pertaining to patent legislation, regulations and decrees that focus, in particular, on TRIPS compliance, TRIPS flexibilities; TRIPS + Provisions, and other general issues relating to patent systems; Data collection, analysis of processes and systems that have been adopted in implementing TRIPS flexibilities, TRIPS+ Provisions, at the practical level in the region and provision of a qualitative assessment of the data collected Recommendations and proposal of strategies for addressing needs and gaps identified at national levels and the establishment of a regional platform for future trade negotiations relating to access to medicines and other pharmaceuticals in the context of the Caribbean Single Market and economy. Development of the data collection instrument Test and modification of the data collation instrument in 2 Member States- one that has a well developed IP system and one with a rudimentary system. Trinidad and Tobago and Guyana; Interviews with the relevant persons and agencies at the country and regional level
Year:	2008 - 2009

Assignment:	Regional assessment of Patent and Intellectual Property issues and Access to Medicines
Client:	CARICOM (Caribbean Community Secretariat)
Country:	St. Lucia
Fields of expertise:	Access to Medicine Campaigns, Appraisal, Drug Regulatory Authority Support, National Medicines Policy Development
Description:	Narrative Description of Project: The general objectives of the Assessment were: To explore the possibilities of developing a harmonized, pro-public health regional (Caribbean) IP regulation and drug policy (to include generic drugs) framework To make recommendations on the IP/patent legislation and regulations that will maximize TRIPS flexibilities while being TRIPS compliant To identify the requirements and process for establishing a regional negotiating platform for drugs To identify mechanisms for building/strengthening coalitions and negotiating positions at the WTO, and in bilateral and regional fora for ensuring access to drugs To make recommendations on the adequacy of the systems in Member States for regulation of the pharmaceutical market to ensure the timely supply of safe, effective and quality medicines. Description of Actual Services Provided: Development of a work plan i consultation with the Technical Advisory Group (TAG) and PANCAP Thorough review of all available literature/documents and prior regional studies pertaining to patent legislation, regulations and decrees that focus, in particular, on TRIPS compliance, TRIPS flexibilities; TRIPS + Provisions, and other general issues relating to patent systems; Data collection, analysis of processes and systems that have been adopted in implementing TRIPS flexibilities, TRIPS+ Provisions, at the practical level in the region and provision of a qualitative assessment of the data collected Recommendations and proposal of strategies for addressing needs and gaps identified at national levels and the establishment of a regional platform for future trade negotiations relating to access to medicines and other pharmaceuticals in the context of the Caribbean Single Market and economy. Development of the data collection instrument Test and modification of the data collation instrument in 2 Member States- one that has a well developed IP system and one with a rudimentary system. Trinidad and Tobago and Guyana; Interviews with the relevant persons and agencies at the country and regional level
Year:	2008 - 2009

Assignment:	Regional assessment of Patent and Intellectual Property issues and Access to Medicines
Client:	CARICOM (Caribbean Community Secretariat)
Country:	Bahamas
Fields of expertise:	Access to Medicine Campaigns, Appraisal, Drug Regulatory Authority Support, National Medicines Policy Development
Description:	Narrative Description of Project: The general objectives of the Assessment were: To explore the possibilities of developing a harmonized, pro-public health regional (Caribbean) IP regulation and drug policy (to include generic drugs) framework To make recommendations on the IP/patent legislation and regulations that will maximize TRIPS flexibilities while being TRIPS compliant To identify the requirements and process for establishing a regional negotiating platform for drugs To identify mechanisms for building/strengthening coalitions and negotiating positions at the WTO, and in bilateral and regional fora for ensuring access to drugs To make recommendations on the adequacy of the systems in Member States for regulation of the pharmaceutical market to ensure the timely supply of safe, effective and quality medicines. Description of Actual Services Provided: Development of a work plan i consultation with the Technical Advisory Group (TAG) and PANCAP Thorough review of all available literature/documents and prior regional studies pertaining to patent legislation, regulations and decrees that focus, in particular, on TRIPS compliance, TRIPS flexibilities; TRIPS + Provisions, and other general issues relating to patent systems; Data collection, analysis of processes and systems that have been adopted in implementing TRIPS flexibilities, TRIPS+ Provisions, at the practical level in the region and provision of a qualitative assessment of the data collected Recommendations and proposal of strategies for addressing needs and gaps identified at national levels and the establishment of a regional platform for future trade negotiations relating to access to medicines and other pharmaceuticals in the context of the Caribbean Single Market and economy. Development of the data collection instrument Test and modification of the data collation instrument in 2 Member States- one that has a well developed IP system and one with a rudimentary system. Trinidad and Tobago and Guyana; Interviews with the relevant persons and agencies at the country and regional level
Year:	2008 - 2009

Assignment:	Regional assessment of Patent and Intellectual Property issues and Access to Medicines
Client:	CARICOM (Caribbean Community Secretariat)
Country:	Belize
Fields of expertise:	Access to Medicine Campaigns, Appraisal, Drug Regulatory Authority Support, National Medicines Policy Development
Description:	Narrative Description of Project: The general objectives of the Assessment were: To explore the possibilities of developing a harmonized, pro-public health regional (Caribbean) IP regulation and drug policy (to include generic drugs) framework To make recommendations on the IP/patent legislation and regulations that will maximize TRIPS flexibilities while being TRIPS compliant To identify the requirements and process for establishing a regional negotiating platform for drugs To identify mechanisms for building/strengthening coalitions and negotiating positions at the WTO, and in bilateral and regional fora for ensuring access to drugs To make recommendations on the adequacy of the systems in Member States for regulation of the pharmaceutical market to ensure the timely supply of safe, effective and quality medicines. Description of Actual Services Provided: Development of a work plan i consultation with the Technical Advisory Group (TAG) and PANCAP Thorough review of all available literature/documents and prior regional studies pertaining to patent legislation, regulations and decrees that focus, in particular, on TRIPS compliance, TRIPS flexibilities; TRIPS + Provisions, and other general issues relating to patent systems; Data collection, analysis of processes and systems that have been adopted in implementing TRIPS flexibilities, TRIPS+ Provisions, at the practical level in the region and provision of a qualitative assessment of the data collected Recommendations and proposal of strategies for addressing needs and gaps identified at national levels and the establishment of a regional platform for future trade negotiations relating to access to medicines and other pharmaceuticals in the context of the Caribbean Single Market and economy. Development of the data collection instrument Test and modification of the data collation instrument in 2 Member States- one that has a well developed IP system and one with a rudimentary system. Trinidad and Tobago and Guyana; Interviews with the relevant persons and agencies at the country and regional level
Year:	2008 - 2009

Assignment:	Regional assessment of Patent and Intellectual Property issues and Access to Medicines
Client:	CARICOM (Caribbean Community Secretariat)
Country:	Montserrat
Fields of expertise:	Access to Medicine Campaigns, Appraisal, Drug Regulatory Authority Support, National Medicines Policy Development
Description:	Narrative Description of Project: The general objectives of the Assessment were: To explore the possibilities of developing a harmonized, pro-public health regional (Caribbean) IP regulation and drug policy (to include generic drugs) framework To make recommendations on the IP/patent legislation and regulations that will maximize TRIPS flexibilities while being TRIPS compliant To identify the requirements and process for establishing a regional negotiating platform for drugs To identify mechanisms for building/strengthening coalitions and negotiating positions at the WTO, and in bilateral and regional fora for ensuring access to drugs To make recommendations on the adequacy of the systems in Member States for regulation of the pharmaceutical market to ensure the timely supply of safe, effective and quality medicines. Description of Actual Services Provided: Development of a work plan i consultation with the Technical Advisory Group (TAG) and PANCAP Thorough review of all available literature/documents and prior regional studies pertaining to patent legislation, regulations and decrees that focus, in particular, on TRIPS compliance, TRIPS flexibilities; TRIPS + Provisions, and other general issues relating to patent systems; Data collection, analysis of processes and systems that have been adopted in implementing TRIPS flexibilities, TRIPS+ Provisions, at the practical level in the region and provision of a qualitative assessment of the data collected Recommendations and proposal of strategies for addressing needs and gaps identified at national levels and the establishment of a regional platform for future trade negotiations relating to access to medicines and other pharmaceuticals in the context of the Caribbean Single Market and economy. Development of the data collection instrument Test and modification of the data collation instrument in 2 Member States- one that has a well developed IP system and one with a rudimentary system. Trinidad and Tobago and Guyana; Interviews with the relevant persons and agencies at the country and regional level
Year:	2009

Assignment:	Regional assessment of Patent and Intellectual Property issues and Access to Medicines
Client:	CARICOM (Caribbean Community Secretariat)
Country:	St. Kitts and Nevis
Fields of expertise:	Access to Medicine Campaigns, Appraisal, Drug Regulatory Authority Support, National Medicines Policy Development
Description:	Narrative Description of Project: The general objectives of the Assessment were: To explore the possibilities of developing a harmonized, pro-public health regional (Caribbean) IP regulation and drug policy (to include generic drugs) framework To make recommendations on the IP/patent legislation and regulations that will maximize TRIPS flexibilities while being TRIPS compliant To identify the requirements and process for establishing a regional negotiating platform for drugs To identify mechanisms for building/strengthening coalitions and negotiating positions at the WTO, and in bilateral and regional fora for ensuring access to drugs To make recommendations on the adequacy of the systems in Member States for regulation of the pharmaceutical market to ensure the timely supply of safe, effective and quality medicines. Description of Actual Services Provided: Development of a work plan i consultation with the Technical Advisory Group (TAG) and PANCAP Thorough review of all available literature/documents and prior regional studies pertaining to patent legislation, regulations and decrees that focus, in particular, on TRIPS compliance, TRIPS flexibilities; TRIPS + Provisions, and other general issues relating to patent systems; Data collection, analysis of processes and systems that have been adopted in implementing TRIPS flexibilities, TRIPS+ Provisions, at the practical level in the region and provision of a qualitative assessment of the data collected Recommendations and proposal of strategies for addressing needs and gaps identified at national levels and the establishment of a regional platform for future trade negotiations relating to access to medicines and other pharmaceuticals in the context of the Caribbean Single Market and economy. Development of the data collection instrument Test and modification of the data collation instrument in 2 Member States- one that has a well developed IP system and one with a rudimentary system. Trinidad and Tobago and Guyana; Interviews with the relevant persons and agencies at the country and regional level
Year:	2008 - 2009

Assignment:	Regional assessment of Patent and Intellectual Property issues and Access to Medicines
Client:	CARICOM (Caribbean Community Secretariat)
Country:	St. Vincent and the Grenadines
Fields of expertise:	Access to Medicine Campaigns, Appraisal, Drug Regulatory Authority Support, National Medicines Policy Development
Description:	Narrative Description of Project: The general objectives of the Assessment were: To explore the possibilities of developing a harmonized, pro-public health regional (Caribbean) IP regulation and drug policy (to include generic drugs) framework To make recommendations on the IP/patent legislation and regulations that will maximize TRIPS flexibilities while being TRIPS compliant To identify the requirements and process for establishing a regional negotiating platform for drugs To identify mechanisms for building/strengthening coalitions and negotiating positions at the WTO, and in bilateral and regional fora for ensuring access to drugs To make recommendations on the adequacy of the systems in Member States for regulation of the pharmaceutical market to ensure the timely supply of safe, effective and quality medicines. Description of Actual Services Provided: Development of a work plan i consultation with the Technical Advisory Group (TAG) and PANCAP Thorough review of all available literature/documents and prior regional studies pertaining to patent legislation, regulations and decrees that focus, in particular, on TRIPS compliance, TRIPS flexibilities; TRIPS + Provisions, and other general issues relating to patent systems; Data collection, analysis of processes and systems that have been adopted in implementing TRIPS flexibilities, TRIPS+ Provisions, at the practical level in the region and provision of a qualitative assessment of the data collected Recommendations and proposal of strategies for addressing needs and gaps identified at national levels and the establishment of a regional platform for future trade negotiations relating to access to medicines and other pharmaceuticals in the context of the Caribbean Single Market and economy. Development of the data collection instrument Test and modification of the data collation instrument in 2 Member States- one that has a well developed IP system and one with a rudimentary system. Trinidad and Tobago and Guyana; Interviews with the relevant persons and agencies at the country and regional level
Year:	2008 - 2009

Assignment:	Regional assessment of Patent and Intellectual Property issues and Access to Medicines
Client:	CARICOM (Caribbean Community Secretariat)
Country:	Trinidad & Tobago
Fields of expertise:	Access to Medicine Campaigns, Appraisal, Drug Regulatory Authority Support, National Medicines Policy Development
Description:	Narrative Description of Project: The general objectives of the Assessment were: To explore the possibilities of developing a harmonized, pro-public health regional (Caribbean) IP regulation and drug policy (to include generic drugs) framework To make recommendations on the IP/patent legislation and regulations that will maximize TRIPS flexibilities while being TRIPS compliant To identify the requirements and process for establishing a regional negotiating platform for drugs To identify mechanisms for building/strengthening coalitions and negotiating positions at the WTO, and in bilateral and regional fora for ensuring access to drugs To make recommendations on the adequacy of the systems in Member States for regulation of the pharmaceutical market to ensure the timely supply of safe, effective and quality medicines. Description of Actual Services Provided: Development of a work plan i consultation with the Technical Advisory Group (TAG) and PANCAP Thorough review of all available literature/documents and prior regional studies pertaining to patent legislation, regulations and decrees that focus, in particular, on TRIPS compliance, TRIPS flexibilities; TRIPS + Provisions, and other general issues relating to patent systems; Data collection, analysis of processes and systems that have been adopted in implementing TRIPS flexibilities, TRIPS+ Provisions, at the practical level in the region and provision of a qualitative assessment of the data collected Recommendations and proposal of strategies for addressing needs and gaps identified at national levels and the establishment of a regional platform for future trade negotiations relating to access to medicines and other pharmaceuticals in the context of the Caribbean Single Market and economy. Development of the data collection instrument Test and modification of the data collation instrument in 2 Member States- one that has a well developed IP system and one with a rudimentary system. Trinidad and Tobago and Guyana; Interviews with the relevant persons and agencies at the country and regional level
Year:	2008 - 2009

Assignment:	Regional assessment of Patent and Intellectual Property issues and Access to Medicines
Client:	CARICOM (Caribbean Community Secretariat)
Country:	Suriname
Fields of expertise:	Access to Medicine Campaigns, Appraisal, Drug Regulatory Authority Support, National Medicines Policy Development
Description:	Narrative Description of Project: The general objectives of the Assessment were: To explore the possibilities of developing a harmonized, pro-public health regional (Caribbean) IP regulation and drug policy (to include generic drugs) framework To make recommendations on the IP/patent legislation and regulations that will maximize TRIPS flexibilities while being TRIPS compliant To identify the requirements and process for establishing a regional negotiating platform for drugs To identify mechanisms for building/strengthening coalitions and negotiating positions at the WTO, and in bilateral and regional fora for ensuring access to drugs To make recommendations on the adequacy of the systems in Member States for regulation of the pharmaceutical market to ensure the timely supply of safe, effective and quality medicines. Description of Actual Services Provided: Development of a work plan i consultation with the Technical Advisory Group (TAG) and PANCAP Thorough review of all available literature/documents and prior regional studies pertaining to patent legislation, regulations and decrees that focus, in particular, on TRIPS compliance, TRIPS flexibilities; TRIPS + Provisions, and other general issues relating to patent systems; Data collection, analysis of processes and systems that have been adopted in implementing TRIPS flexibilities, TRIPS+ Provisions, at the practical level in the region and provision of a qualitative assessment of the data collected Recommendations and proposal of strategies for addressing needs and gaps identified at national levels and the establishment of a regional platform for future trade negotiations relating to access to medicines and other pharmaceuticals in the context of the Caribbean Single Market and economy. Development of the data collection instrument Test and modification of the data collation instrument in 2 Member States- one that has a well developed IP system and one with a rudimentary system. Trinidad and Tobago and Guyana; Interviews with the relevant persons and agencies at the country and regional level
Year:	2008 - 2009

Assignment:	Evaluation of VEN classification and choice of stock items at the Medical Stores Department (MSD) & Review NEML & contents Drug Kits in Zanzibar
Client:	Danida
Country:	Tanzania / Zanzibar
Fields of expertise:	Medical Store Evaluation, National Medicines Policy Development, Selection of Essential Medicines
Description:	Narrative Description of Project: MSD’s VEN classification and the choice of stock items is the basis for the management of the supply of health commodities to the public health facilities in Tanzania. Based on the National Drug Policy, the Standard Treatment Guidelines and the National Essential Medicines List of Tanzania (NEMLIT) a VEN classification needed to be developed. (VEN= vital, essential or necessary) In Zanzibar (separate, autonomous MOH), the Zanzibar Essential Medicines List also needed to be updated. Description of Actual Services Provided: Tanzania Assist the local team in revisiting the NEMLIT and the Standard Treatment Guidelines and based on the present practice, evidence and WHO recommendations, propose changes to both documents Assist the local team to develop a new classification of VEN based on the present situation (field visits, interviews) Re-evaluate the whole choice of MSD’s stock items Classify MSD range stock after the VEN classification Zanibar Assess whether the draft standard Treatment Guidelines are in line with the most current best practices for the treatment of the most common public health problems in Zanzibar Ensure that the Essential Medicines List for Zanzibar will be updated in line with the current EML as recommended by WHO Ensure that the updated EML for Zanzibar will address the needs of the public health facilities in Zanzibar Provide advice on modalities that will ensure a regular update of the EML for Zanzibar inline with new insights regarding the treatment of the most common public health problems. Advise with the revision of the contents of the currently used Drug Kits for the different levels of health care provision in Zanzibar.
Year:	2005 - 2007

Assignment:	Review of the Expanded Programme of Immunisation (EPI)
Client:	Danida - Ministry of Health
Country:	Tanzania / Zanzibar
Fields of expertise:	Basic Health Services, Monitoring and Evaluation, National Medicines Policy Development, Planning, Organisation and Management, Procurement and Tender Support
Description:	Narrative Description of Project: Review of the actual immunisation operations in Tanzania Identification of the needs to improve the immunisation programme.
Year:	2000

Assignment:	Medicines Transparency Alliance (MeTA)
Client:	DFID
Country:	Jordan
Fields of expertise:	Access to Medicine Campaigns, Drug Regulatory Authority Support, Drug Supply Management System Strengthening, Essential Drugs Programme Support, Increasing Transparency In Public And Private Pharmaceutical Markets, National Medicines Policy Development, Procurement and Tender Support, Public Private Partnership Interventions, Training and Human Resource Development
Description:	Narrative description of Project: MeTA is a new multi-stakeholder approach for increasing transparency around the selection, procurement, sale and distribution of medicines in Low Income Countries, thereby strengthening governance and encouraging responsible business practices. The MeTA goal is to ensure access to affordable essential drugs in developing countries (MDG 8, target 17). The initiative us being supported financially by DFID during its present Phase One. MeTA brings together, at both the international and national levels, a diverse group of people with an interest in the pharmaceutical sector (stakeholders) to find ways to improve information flows, and increase transparency and accountability about the selection, regulation, procurement, sale, distribution and use of medicines in developing countries. By doing so, MeTA will improve how decisions are made about medicines, improve the way they are purchased and supplied, encourage innovative and responsible business practices, and increase the voice of patients and consumers. Description of actual services provided by your staff within the assignment: The MeTA International Secretariat is tasked to help to support the implementation of MeTA in 7 pilot countries, through facilitating support for the evolution and effective functioning of the National Secretariats, National Multi-Stakeholder Group (NMSGs), and implementation of work plans. Following the establishment of country MeTA structures, the International MeTA Secretariat provides further support to the pilot countries including: Supporting countries to extract and collate data on medicine quality, availability and pricing along the supply chain; Supporting countries to undertake studies assessing the level of transparency and good governance in medicines regulation and procurement; Working with countries to produce country-specific MeTA reports, which would collate data and further analyse and contextualise issues related to medicine quality, availability and price, and to disseminate these reports through the media and public interest groups; as well as exploring policy options and support needed for implementation e.g. of report recommendations. Assist countries in using the data collated through MeTA on medicine policies and regulation as well as quality, availability and prices to try to promote relevant good practice and policy changes to improve access to medicines. HERA contracted staff are responsible for the provision of country specific support under META. Pilot countries are: Ghana, Uganda, Zambia, the Philippines, Jordan, Kyrgyzstan and Peru.
Year:	2008 - 2010

Assignment:	Medicines Transparency Alliance (MeTA)
Client:	DFID
Country:	Ghana
Fields of expertise:	Access to Medicine Campaigns, Drug Pricing Studies, Drug Regulatory Authority Support, Drug Supply Management System Strengthening, Essential Drugs Programme Support, Essential Medicines Financing, Increasing Transparency In Public And Private Pharmaceutical Markets, National Medicines Policy Development, Procurement and Tender Support, Public Private Partnership Interventions, Rational Use Surveys, Training and Human Resource Development
Description:	Narrative description of Project: MeTA is a new multi-stakeholder approach for increasing transparency around the selection, procurement, sale and distribution of medicines in Low Income Countries, thereby strengthening governance and encouraging responsible business practices. The MeTA goal is to ensure access to affordable essential drugs in developing countries (MDG 8, target 17). The initiative us being supported financially by DFID during its present Phase One. MeTA brings together, at both the international and national levels, a diverse group of people with an interest in the pharmaceutical sector (stakeholders) to find ways to improve information flows, and increase transparency and accountability about the selection, regulation, procurement, sale, distribution and use of medicines in developing countries. By doing so, MeTA will improve how decisions are made about medicines, improve the way they are purchased and supplied, encourage innovative and responsible business practices, and increase the voice of patients and consumers. Description of actual services provided by your staff within the assignment: The MeTA International Secretariat is tasked to help to support the implementation of MeTA in 7 pilot countries, through facilitating support for the evolution and effective functioning of the National Secretariats, National Multi-Stakeholder Group (NMSGs), and implementation of work plans. Following the establishment of country MeTA structures, the International MeTA Secretariat provides further support to the pilot countries including: Supporting countries to extract and collate data on medicine quality, availability and pricing along the supply chain; Supporting countries to undertake studies assessing the level of transparency and good governance in medicines regulation and procurement; Working with countries to produce country-specific MeTA reports, which would collate data and further analyse and contextualise issues related to medicine quality, availability and price, and to disseminate these reports through the media and public interest groups; as well as exploring policy options and support needed for implementation e.g. of report recommendations. Assist countries in using the data collated through MeTA on medicine policies and regulation as well as quality, availability and prices to try to promote relevant good practice and policy changes to improve access to medicines. HERA contracted staff are responsible for the provision of country specific support under META. Pilot countries are: Ghana, Uganda, Zambia, the Philippines, Jordan, Kyrgyzstan and Peru.
Year:	2008 - 2010

Assignment:	Medicines Transparency Alliance (MeTA)
Client:	DFID
Country:	Kyrgyzstan
Fields of expertise:	Access to Medicine Campaigns, Drug Pricing Studies, Drug Regulatory Authority Support, Drug Supply Management System Strengthening, Essential Drugs Programme Support, Essential Medicines Financing, Increasing Transparency In Public And Private Pharmaceutical Markets, National Medicines Policy Development, Public Private Partnership Interventions, Rational Use Surveys, Training and Human Resource Development
Description:	Narrative description of Project: MeTA is a new multi-stakeholder approach for increasing transparency around the selection, procurement, sale and distribution of medicines in Low Income Countries, thereby strengthening governance and encouraging responsible business practices. The MeTA goal is to ensure access to affordable essential drugs in developing countries (MDG 8, target 17). The initiative us being supported financially by DFID during its present Phase One. MeTA brings together, at both the international and national levels, a diverse group of people with an interest in the pharmaceutical sector (stakeholders) to find ways to improve information flows, and increase transparency and accountability about the selection, regulation, procurement, sale, distribution and use of medicines in developing countries. By doing so, MeTA will improve how decisions are made about medicines, improve the way they are purchased and supplied, encourage innovative and responsible business practices, and increase the voice of patients and consumers. Description of actual services provided by your staff within the assignment: The MeTA International Secretariat is tasked to help to support the implementation of MeTA in 7 pilot countries, through facilitating support for the evolution and effective functioning of the National Secretariats, National Multi-Stakeholder Group (NMSGs), and implementation of work plans. Following the establishment of country MeTA structures, the International MeTA Secretariat provides further support to the pilot countries including: Supporting countries to extract and collate data on medicine quality, availability and pricing along the supply chain; Supporting countries to undertake studies assessing the level of transparency and good governance in medicines regulation and procurement; Working with countries to produce country-specific MeTA reports, which would collate data and further analyse and contextualise issues related to medicine quality, availability and price, and to disseminate these reports through the media and public interest groups; as well as exploring policy options and support needed for implementation e.g. of report recommendations. Assist countries in using the data collated through MeTA on medicine policies and regulation as well as quality, availability and prices to try to promote relevant good practice and policy changes to improve access to medicines. HERA contracted staff are responsible for the provision of country specific support under META. Pilot countries are: Ghana, Uganda, Zambia, the Philippines, Jordan, Kyrgyzstan and Peru.
Year:	2008 - 2010

Assignment:	Medicines Transparency Alliance (MeTA)
Client:	DFID
Country:	Peru
Fields of expertise:	Access to Medicine Campaigns, Drug Pricing Studies, Drug Regulatory Authority Support, Drug Supply Management System Strengthening, Essential Drugs Programme Support, Essential Medicines Financing, Increasing Transparency In Public And Private Pharmaceutical Markets, National Medicines Policy Development, Public Private Partnership Interventions, Rational Use Surveys, Training and Human Resource Development
Description:	Narrative description of Project: MeTA is a new multi-stakeholder approach for increasing transparency around the selection, procurement, sale and distribution of medicines in Low Income Countries, thereby strengthening governance and encouraging responsible business practices. The MeTA goal is to ensure access to affordable essential drugs in developing countries (MDG 8, target 17). The initiative us being supported financially by DFID during its present Phase One. MeTA brings together, at both the international and national levels, a diverse group of people with an interest in the pharmaceutical sector (stakeholders) to find ways to improve information flows, and increase transparency and accountability about the selection, regulation, procurement, sale, distribution and use of medicines in developing countries. By doing so, MeTA will improve how decisions are made about medicines, improve the way they are purchased and supplied, encourage innovative and responsible business practices, and increase the voice of patients and consumers. Description of actual services provided by your staff within the assignment: The MeTA International Secretariat is tasked to help to support the implementation of MeTA in 7 pilot countries, through facilitating support for the evolution and effective functioning of the National Secretariats, National Multi-Stakeholder Group (NMSGs), and implementation of work plans. Following the establishment of country MeTA structures, the International MeTA Secretariat provides further support to the pilot countries including: Supporting countries to extract and collate data on medicine quality, availability and pricing along the supply chain; Supporting countries to undertake studies assessing the level of transparency and good governance in medicines regulation and procurement; Working with countries to produce country-specific MeTA reports, which would collate data and further analyse and contextualise issues related to medicine quality, availability and price, and to disseminate these reports through the media and public interest groups; as well as exploring policy options and support needed for implementation e.g. of report recommendations. Assist countries in using the data collated through MeTA on medicine policies and regulation as well as quality, availability and prices to try to promote relevant good practice and policy changes to improve access to medicines. HERA contracted staff are responsible for the provision of country specific support under META. Pilot countries are: Ghana, Uganda, Zambia, the Philippines, Jordan, Kyrgyzstan and Peru.
Year:	2008 - 2010

Assignment:	Medicines Transparency Alliance (MeTA)
Client:	DFID
Country:	The Philippines
Fields of expertise:	Access to Medicine Campaigns, Drug Pricing Studies, Drug Regulatory Authority Support, Drug Supply Management System Strengthening, Essential Drugs Programme Support, Essential Medicines Financing, Increasing Transparency In Public And Private Pharmaceutical Markets, National Medicines Policy Development, Public Private Partnership Interventions, Rational Use Surveys, Training and Human Resource Development
Description:	Narrative description of Project: MeTA is a new multi-stakeholder approach for increasing transparency around the selection, procurement, sale and distribution of medicines in Low Income Countries, thereby strengthening governance and encouraging responsible business practices. The MeTA goal is to ensure access to affordable essential drugs in developing countries (MDG 8, target 17). The initiative us being supported financially by DFID during its present Phase One. MeTA brings together, at both the international and national levels, a diverse group of people with an interest in the pharmaceutical sector (stakeholders) to find ways to improve information flows, and increase transparency and accountability about the selection, regulation, procurement, sale, distribution and use of medicines in developing countries. By doing so, MeTA will improve how decisions are made about medicines, improve the way they are purchased and supplied, encourage innovative and responsible business practices, and increase the voice of patients and consumers. Description of actual services provided by your staff within the assignment: The MeTA International Secretariat is tasked to help to support the implementation of MeTA in 7 pilot countries, through facilitating support for the evolution and effective functioning of the National Secretariats, National Multi-Stakeholder Group (NMSGs), and implementation of work plans. Following the establishment of country MeTA structures, the International MeTA Secretariat provides further support to the pilot countries including: Supporting countries to extract and collate data on medicine quality, availability and pricing along the supply chain; Supporting countries to undertake studies assessing the level of transparency and good governance in medicines regulation and procurement; Working with countries to produce country-specific MeTA reports, which would collate data and further analyse and contextualise issues related to medicine quality, availability and price, and to disseminate these reports through the media and public interest groups; as well as exploring policy options and support needed for implementation e.g. of report recommendations. Assist countries in using the data collated through MeTA on medicine policies and regulation as well as quality, availability and prices to try to promote relevant good practice and policy changes to improve access to medicines. HERA contracted staff are responsible for the provision of country specific support under META. Pilot countries are: Ghana, Uganda, Zambia, the Philippines, Jordan, Kyrgyzstan and Peru.
Year:	2008 - 2010

Assignment:	Medicines Transparency Alliance (MeTA)
Client:	DFID
Country:	Uganda
Fields of expertise:	Access to Medicine Campaigns, Drug Pricing Studies, Drug Regulatory Authority Support, Drug Supply Management System Strengthening, Essential Drugs Programme Support, Essential Medicines Financing, Increasing Transparency In Public And Private Pharmaceutical Markets, National Medicines Policy Development, Public Private Partnership Interventions, Rational Use Surveys, Training and Human Resource Development
Description:	Narrative description of Project: MeTA is a new multi-stakeholder approach for increasing transparency around the selection, procurement, sale and distribution of medicines in Low Income Countries, thereby strengthening governance and encouraging responsible business practices. The MeTA goal is to ensure access to affordable essential drugs in developing countries (MDG 8, target 17). The initiative us being supported financially by DFID during its present Phase One. MeTA brings together, at both the international and national levels, a diverse group of people with an interest in the pharmaceutical sector (stakeholders) to find ways to improve information flows, and increase transparency and accountability about the selection, regulation, procurement, sale, distribution and use of medicines in developing countries. By doing so, MeTA will improve how decisions are made about medicines, improve the way they are purchased and supplied, encourage innovative and responsible business practices, and increase the voice of patients and consumers. Description of actual services provided by your staff within the assignment: The MeTA International Secretariat is tasked to help to support the implementation of MeTA in 7 pilot countries, through facilitating support for the evolution and effective functioning of the National Secretariats, National Multi-Stakeholder Group (NMSGs), and implementation of work plans. Following the establishment of country MeTA structures, the International MeTA Secretariat provides further support to the pilot countries including: Supporting countries to extract and collate data on medicine quality, availability and pricing along the supply chain; Supporting countries to undertake studies assessing the level of transparency and good governance in medicines regulation and procurement; Working with countries to produce country-specific MeTA reports, which would collate data and further analyse and contextualise issues related to medicine quality, availability and price, and to disseminate these reports through the media and public interest groups; as well as exploring policy options and support needed for implementation e.g. of report recommendations. Assist countries in using the data collated through MeTA on medicine policies and regulation as well as quality, availability and prices to try to promote relevant good practice and policy changes to improve access to medicines. HERA contracted staff are responsible for the provision of country specific support under META. Pilot countries are: Ghana, Uganda, Zambia, the Philippines, Jordan, Kyrgyzstan and Peru.
Year:	2008 - 2010

Assignment:	Medicines Transparency Alliance (MeTA)
Client:	DFID
Country:	Zambia
Fields of expertise:	Access to Medicine Campaigns, Drug Pricing Studies, Drug Regulatory Authority Support, Drug Supply Management System Strengthening, Essential Drugs Programme Support, Essential Medicines Financing, Increasing Transparency In Public And Private Pharmaceutical Markets, National Medicines Policy Development, Public Private Partnership Interventions, Rational Use Surveys, Training and Human Resource Development
Description:	Narrative description of Project: MeTA is a new multi-stakeholder approach for increasing transparency around the selection, procurement, sale and distribution of medicines in Low Income Countries, thereby strengthening governance and encouraging responsible business practices. The MeTA goal is to ensure access to affordable essential drugs in developing countries (MDG 8, target 17). The initiative us being supported financially by DFID during its present Phase One. MeTA brings together, at both the international and national levels, a diverse group of people with an interest in the pharmaceutical sector (stakeholders) to find ways to improve information flows, and increase transparency and accountability about the selection, regulation, procurement, sale, distribution and use of medicines in developing countries. By doing so, MeTA will improve how decisions are made about medicines, improve the way they are purchased and supplied, encourage innovative and responsible business practices, and increase the voice of patients and consumers. Description of actual services provided by your staff within the assignment: The MeTA International Secretariat is tasked to help to support the implementation of MeTA in 7 pilot countries, through facilitating support for the evolution and effective functioning of the National Secretariats, National Multi-Stakeholder Group (NMSGs), and implementation of work plans. Following the establishment of country MeTA structures, the International MeTA Secretariat provides further support to the pilot countries including: Supporting countries to extract and collate data on medicine quality, availability and pricing along the supply chain; Supporting countries to undertake studies assessing the level of transparency and good governance in medicines regulation and procurement; Working with countries to produce country-specific MeTA reports, which would collate data and further analyse and contextualise issues related to medicine quality, availability and price, and to disseminate these reports through the media and public interest groups; as well as exploring policy options and support needed for implementation e.g. of report recommendations. Assist countries in using the data collated through MeTA on medicine policies and regulation as well as quality, availability and prices to try to promote relevant good practice and policy changes to improve access to medicines. HERA contracted staff are responsible for the provision of country specific support under META. Pilot countries are: Ghana, Uganda, Zambia, the Philippines, Jordan, Kyrgyzstan and Peru.
Year:	2008 - 2010

Assignment:	Mid-term Review of EC/ACP/WHO Partnership on Pharmaceutical Policies
Client:	EC - AIDCO
Country:	Global
Fields of expertise:	Drug Regulatory Authority Support, Essential Drugs Programme Support, Essential Medicines Financing, Monitoring and Evaluation, National Medicines Policy Development
Description:	Narrative Description of Project: Study of the achievements of the programme, its contribution to the overall objective, and performance in terms of programme purpose and results. Estimation of the quality of work planning, budgeting and risk management. Analysis of constraints and proposal of solutions. Analysis of the degree of coherence of the programme with the country national drugs plans at governmental level and activities undertaken by the relevant stakeholders,. Analysis of the degree of coordination and complementarities of project’s activities with other donor’s activities at country and global levels. Analysis of the degree of sustainability of project benefits Analysis of the degree of respect of EU visibility and publicity in WHO implementation approach. Proposal of measures and recommendations for change to project scope in order to support effective implementation. Description of Actual Services Provided: Briefing in Brussels with EU services AIDCO/C/4 Desk-audits and interviews at WHO Offices in Geneva Visits to regional offices: Brazzaville and Manila Country visits to Nigeria and Tanzania: contacts with officials at the EC Delegations, and the key donors in pharmaceutical and essential medicine area and field visits. Draft report summarizing findings and recommendations Validation workshop in Brussels Submission Final Report
Year:	2006

Assignment:	Pre-feasibility and Feasibility Study of the "Health Sector and Demography Support"
Client:	EC - AIDCO
Country:	Yemen
Fields of expertise:	Appraisal, Basic Health Services, Health Expenditure Review, Health Policy and Policy Dialogue, Health Sector Reform, Health Sector Review or Health Sector Diagnosis, Hospital Services, National Medicines Policy Development, Planning, Organisation and Management, Reproductive Health, Training and Human Resource Development
Description:	Narrative Description of Project: Both studies will provide the decision-makers in the Government of Yemen and the European Commission with a proposal for the future design of the project “Health Sector and Demography Support”. The proposed project design will take into account the recommendations of the pre-feasibility study carried out on 2002 as well as the key issues of the ongoing discussions between the Ministry of Public health and Population and the EC services since then. Description of Actual Services Provided: Health sector review : analysis of Yemen’s health sector reform plan and implementation; performance of the health sector; analysis of public and private health expenditure; management and implementation capacity of existing providers; human resources development policy; essential drugs policy and supply; demography and reproductive health; Stages of sectoral review using the logframe methodology Recommendations about the strategic choices to be made; Participatory strategy analysis and planning workshops at the Governorate level using the logframe methodology according to EC standards; Establish links with possible EC support to National Population Council. Study reproductive health issues and gender roles and interests relating to these services. A precise proposal on the organisation of the project and the technical inputs necessary to achieve the objectives of the project. Presentation of the proposed project to the central level and to the major stakeholders Draft Financing Proposal and TAPS; Analysis of constraints to efficient service delivery and propose solutions; Human resource management and performance.
Year:	2002 - 2003

Assignment:	Mid-term Review of EC/ACP/WHO Partnership on Pharmaceutical Policies
Client:	EC - AIDCO
Country:	Nigeria
Fields of expertise:	Drug Regulatory Authority Support, Essential Drugs Programme Support, Essential Medicines Financing, Monitoring and Evaluation, National Medicines Policy Development
Description:	Narrative Description of Project: Study of the achievements of the programme, its contribution to the overall objective, and performance in terms of programme purpose and results. Estimation of the quality of work planning, budgeting and risk management. Analysis of constraints and proposal of solutions. Analysis of the degree of coherence of the programme with the country national drugs plans at governmental level and activities undertaken by the relevant stakeholders,. Analysis of the degree of coordination and complementarities of project’s activities with other donor’s activities at country and global levels. Analysis of the degree of sustainability of project benefits Analysis of the degree of respect of EU visibility and publicity in WHO implementation approach. Proposal of measures and recommendations for change to project scope in order to support effective implementation. Description of Actual Services Provided: Briefing in Brussels with EU services AIDCO/C/4 Desk-audits and interviews at WHO Offices in Geneva Visits to regional offices: Brazzaville and Manila Country visits to Nigeria and Tanzania: contacts with officials at the EC Delegations, and the key donors in pharmaceutical and essential medicine area and field visits. Draft report summarizing findings and recommendations Validation workshop in Brussels Submission Final Report
Year:	2006

Assignment:	Mid-term Review of EC/ACP/WHO Partnership on Pharmaceutical Policies
Client:	EC - AIDCO
Country:	Tanzania / Zanzibar
Fields of expertise:	Drug Regulatory Authority Support, Essential Drugs Programme Support, Essential Medicines Financing, Monitoring and Evaluation, National Medicines Policy Development
Description:	Narrative Description of Project: Study of the achievements of the programme, its contribution to the overall objective, and performance in terms of programme purpose and results. Estimation of the quality of work planning, budgeting and risk management. Analysis of constraints and proposal of solutions. Analysis of the degree of coherence of the programme with the country national drugs plans at governmental level and activities undertaken by the relevant stakeholders,. Analysis of the degree of coordination and complementarities of project’s activities with other donor’s activities at country and global levels. Analysis of the degree of sustainability of project benefits Analysis of the degree of respect of EU visibility and publicity in WHO implementation approach. Proposal of measures and recommendations for change to project scope in order to support effective implementation. Description of Actual Services Provided: Briefing in Brussels with EU services AIDCO/C/4 Desk-audits and interviews at WHO Offices in Geneva Visits to regional offices: Brazzaville and Manila Country visits to Nigeria and Tanzania: contacts with officials at the EC Delegations, and the key donors in pharmaceutical and essential medicine area and field visits. Draft report summarizing findings and recommendations Validation workshop in Brussels Submission Final Report
Year:	2006

Assignment:	Mid-term Review of EC/ACP/WHO Partnership on Pharmaceutical Policies
Client:	EC - AIDCO
Country:	Congo Brazzaville
Fields of expertise:	Drug Regulatory Authority Support, Essential Drugs Programme Support, Essential Medicines Financing, Monitoring and Evaluation, National Medicines Policy Development
Description:	Narrative Description of Project: Study of the achievements of the programme, its contribution to the overall objective, and performance in terms of programme purpose and results. Estimation of the quality of work planning, budgeting and risk management. Analysis of constraints and proposal of solutions. Analysis of the degree of coherence of the programme with the country national drugs plans at governmental level and activities undertaken by the relevant stakeholders,. Analysis of the degree of coordination and complementarities of project’s activities with other donor’s activities at country and global levels. Analysis of the degree of sustainability of project benefits Analysis of the degree of respect of EU visibility and publicity in WHO implementation approach. Proposal of measures and recommendations for change to project scope in order to support effective implementation. Description of Actual Services Provided: Briefing in Brussels with EU services AIDCO/C/4 Desk-audits and interviews at WHO Offices in Geneva Visits to regional offices: Brazzaville and Manila Country visits to Nigeria and Tanzania: contacts with officials at the EC Delegations, and the key donors in pharmaceutical and essential medicine area and field visits. Draft report summarizing findings and recommendations Validation workshop in Brussels Submission Final Report
Year:	2006

Assignment:	Mid-term Review of EC/ACP/WHO Partnership on Pharmaceutical Policies
Client:	EC - AIDCO
Country:	The Philippines
Fields of expertise:	Drug Regulatory Authority Support, Essential Drugs Programme Support, Essential Medicines Financing, Monitoring and Evaluation, National Medicines Policy Development
Description:	Narrative Description of Project: Study of the achievements of the programme, its contribution to the overall objective, and performance in terms of programme purpose and results. Estimation of the quality of work planning, budgeting and risk management. Analysis of constraints and proposal of solutions. Analysis of the degree of coherence of the programme with the country national drugs plans at governmental level and activities undertaken by the relevant stakeholders,. Analysis of the degree of coordination and complementarities of project’s activities with other donor’s activities at country and global levels. Analysis of the degree of sustainability of project benefits Analysis of the degree of respect of EU visibility and publicity in WHO implementation approach. Proposal of measures and recommendations for change to project scope in order to support effective implementation. Description of Actual Services Provided: Briefing in Brussels with EU services AIDCO/C/4 Desk-audits and interviews at WHO Offices in Geneva Visits to regional offices: Brazzaville and Manila Country visits to Nigeria and Tanzania: contacts with officials at the EC Delegations, and the key donors in pharmaceutical and essential medicine area and field visits. Draft report summarizing findings and recommendations Validation workshop in Brussels Submission Final Report
Year:	2006

Assignment:	Change review of Namibia Integrated Health Programme
Client:	EC - KIT
Country:	Namibia
Fields of expertise:	Basic Health Services, Drug Supply Management System Strengthening, Essential Drugs Programme Support, Health Policy and Policy Dialogue, Health Sector Reform, Monitoring and Evaluation, National Medicines Policy Development, Planning, Organisation and Management
Description:	Narrative Description of Project: The different components of the NHIP programme are the following: Support to central level Support the intermediate and operational regional levels Support to the essential drug programme NIHP’s general objectives are in a nutshell: to promote comprehensive development of the central level of the MOHSS, with particular emphasis on strengthening the administrative and financial services; to support the process of decentralisation of the health system and to improve the delivery of comprehensive primary health care by strengthening Regional Health Directorates and regional Health Management Teams (RHMT); to support the planning and development of an Essential Drugs Programme (EDP) by enhancing rational and cost-effective procurement, storage, distribution, supply and use of pharmaceutical products and medical supplies. Description of Actual Services Provided: Review of Namibia Integrated Health Programme and change review of the health sector reform process performance. Recommendations for the future.
Year:	1999

Assignment:	Review of the Pharmaceutical Sector
Client:	EC/EDF
Country:	Madagascar
Fields of expertise:	Costing Studies, Drug Supply Management System Strengthening, Essential Drugs Programme Support, Health Financing and Provider Payment, Identification and Formulation, Medical Store Evaluation, National Medicines Policy Development, Pharmaceutical Sector Review
Description:	Narrative Description of Project: Analysis of the pharmaceutical sector. Elaboration of a proposal of a new central medical store. Description of Actual Services Provided: Analysis and evaluation of the pharmaceutical sector. Project proposal of new central medical stores. Development of distribution mechanisms (up to the periphery). Cost-recovery schemes. Appraisal study of the central medical store. The central medical store (SALAMA) which is actually operational in Atananarivo is the result of the technical and organisational proposals made by HERA.
Year:	1994 - 1995

Assignment:	Monitoring of the EC Support to the Health Sector Reform Project (HSRP)
Client:	European Commission - Ministry of Health
Country:	Egypt
Fields of expertise:	Basic Health Services, Essential Drugs Programme Support, Health Financing and Provider Payment, Health Insurance, Health Policy and Policy Dialogue, Health Sector Reform, Hospital Services, Long Term Technical Assistance, Monitoring and Evaluation, Monitoring and Evaluation, National Medicines Policy Development, Planning, Organisation and Management, Public Private Partnership
Description:	Narrative Description of Project: The Ministry of Health has launched a Health Sector Reform Project (HSRP)). This programme aims at organising the health services towards families and being financed by health insurance. A pilot model of family health services has been created in 3 Governorates. This model has been operated by the Ministry of Health, the Health Insurance Organisation (HIO) and the private sector. The Ministry of Health wishes to develop a health insurance system and to reach national coverage. The European Commission provides support to this reform through budgetary help for the Family Health Fund, annual activity programmes and technical assistance programmes. Moreover. Description of Actual Services Provided: An external team monitors the process of the reform and gives advise to the Ministry of Health and the EC to improve the impact of the reform strategies. HERA provided the team leader to the monitoring team. Bi-annual missions were carried out between 2001-2006. Monitoring, on behalf of the EC, the progress of the health sector reform and health insurance reform in Egypt (over a 5-year period); Advise the Ministry of Health and Population on reform concepts, policy development, processes and change; Advise the EC on Tranche Release for the sector reform.
Year:	2000 - 2004

Assignment:	Pre-feasibility Study of local production of quality anti-retroviral drugs
Client:	Kreditanstalt für Wiederaufbau
Country:	Rwanda
Fields of expertise:	Appraisal, Cost-effectiveness Studies, Costing Studies, Drug Supply Management System Strengthening, National Medicines Policy Development, Public Private Partnership Interventions, Quantification of Essential Drug Needs
Description:	Narrative Description of Project: The objective of the study is to analyse whether ARV production in Rwanda is feasible and would lead to an increased availability of accessible quality drugs in Rwanda and whether there is a potential for export in the sub-region. The second question concerns the best way to implement such a project and whether a cooperation of German development cooperation with Pharmakina could lead to success. Risks and alternatives are also evaluated. Description of Actual Services Provided: Specific tasks Local and regional market and distribution assessment Economic and financial analysis Institutional and organisational analysis Production process technical analysis To evaluate the overall justification in the context of the targets of the German development cooperation Methods Bilateral discussions with MoH and other institutions and donors active in the given filed in Rwanda (GTZ Rwanda: Health and WIRAM (Economy reform and market development, etc.), Revision of available documents, Close cooperation with MoH, GTZ-Rwanda Debriefing meeting in Rwanda Elaboration of a final evaluation report (business plan)
Year:	2005

Assignment:	Pharmaceutical System Assessment
Client:	Ministry of Health
Country:	Lesotho
Fields of expertise:	Essential Drugs Programme Support, Essential Medicines Financing, National Medicines Policy Development, Pharmaceutical Sector Review, Procurement and Tender Support, Public Private Partnership Interventions, Rational Use Surveys, Training and Human Resource Development
Description:	Narrative Description of Project: To carry out a comprehensive review of the Pharmaceutical systems in Lesotho, to make proposals and assist the Pharmaceutical Department to define and begin to implement a programme of reforms. Description of Actual Services Provided: General assessment of pharmaceutical management (MOHSW pharmaceuticals dept, CHAL, LPC, NDSO) Policy review: review of draft National Drug Policy Review of procurement process Assess methodology of procuring drugs Assess adequacy of present QA system Drug financing: review sources of funding, assess management of drug budget Pharmaceutical information system Rational Drug use Preparation for drug registration Human resources Private-public sector: analysis capacity/efficiency ; price comparison Capacity building Assist implementation
Year:	2002 - 2003

Assignment:	Development of Capacity for the procurement of Pharmaceuticals and other Health goods and services & strengthening of management capacity of the Drug Supply Company Suriname (BGVS)
Client:	Ministry of Health
Country:	Suriname
Fields of expertise:	Costing Studies, Drug Supply Management System Strengthening, Essential Drugs Programme Support, Essential Medicines Financing, National Medicines Policy Development, Procurement and Tender Support, Training and Human Resource Development
Description:	Narrative description of Project: The overall objective of the technical assistance (TA) for the Procurement and Supply Consultancy and BGVS Management Support Services for the Ministry of Health in Suriname is to establish internationally accepted procurement and supply functions in the health sector, as well as the necessary management arrangements that will facilitate Goods Procurement Practises at the BGVS. Description of actual services provided: The team provided the necessary support to the MOH Pharmaceutical Policy Coordinator with the development of procurement organization and planning as well as storage and distribution of commodities. More specifically assisted the MOH and its programs in the set-up of its institutional framework for procurement of Goods, Works and Services and assisted the BGVS Board of Directors and management in formulating and executing its policy for 2007-2008, which is currently being drafted. The focus lay on: Procurement and supply management activities with regard to essential drugs and supplies at GBVS as well as at MOH and its programs; Development and implementation of harmonized procurement and supply systems, including procedures, quality assurance, administration, monitoring, documentation, …; Recruitment and training of staff to undertake aforementioned tasks; Building working relationships with all stakeholders, including sensitizing senior staff in the public health system on sound procurement systems and procedures; Training and skills transfer regarding Good Procurement Practises at central and BGVS level; Financial management, including costing and pricing of goods and credit control at BGVS; Evaluation of data management at BGVS, with a focus on management information systems and taking into account specific requirements of clients and stakeholders.
Year:	2007 - 2008

Assignment:	Mid-term Review of the National Health Strategic Plan 2006-2010
Client:	Ministry of Health - Zambia
Country:	Zambia
Fields of expertise:	Drug Supply Management System Strengthening, Health Financing and Provider Payment, Monitoring and Evaluation, National Medicines Policy Development, Procurement and Tender Support
Description:	Narrative description of Project: The primary aim of the Mid-Term Review (MTR) was to assess progress in the implementation of the current strategic plan, identify strengths, weaknesses, opportunities and threats that should be cultivated towards accelerated implementation in the remaining half of the term. Secondly, the review will generate key recommendations that can be used to determine possible modifications of the NHSP on sector-specific interventions in order to accelerate the implementation of the plan to attain the health MDGs. Description of actual services provided by your staff within the assignment: The consultant participated in the subgroup Support Systems (SS) and more specifically in the area of Procurement Management System and national drug policy. The team assessed the capacity of the MoH to carry out different phases of the procurement cycle focusing on the organizational aspects; skills of the staff; quality and adequacy of supporting and control systems; record keeping; the general procurement environment and the private sector assessment. In addition the various pharmaceutical policy documents were looked at and assessed. For each area, key questions to initiate discussions during the various interviews were prepared based on the analysis of the available documentation. The questions related closely to the objectives and indicators for the various components of NHSP IV.
Year:	2008

Assignment:	Strengthening of Pharmaceutical Quality Assurance & Legislation
Client:	Ministry of Health Suriname
Country:	Suriname
Fields of expertise:	National Medicines Policy Development, Pharmaceutical Sector Review
Description:	Narrative description of Project: The overall objective of the Technical Assistance (TA) and the subsequent review and drafting of legislation is to establish quality assurance protocols and procedures which are backed by legislation, and the necessary technical and operational infrastructure. Specific recommendations on structures that should be in place to ensure that all medicines on the market and the pharmaceutical services are safe and effective and that they adhere to international standards and recommendations, as well as a review and drafting of all pharmacy related legislation will be presented. Description of actual services provided: The TA provided support to the MOH Pharmaceutical Policy Coordinator and the MOH legislation department with the development of quality assurance infrastructure, comprehending (i) relevant legislation and regulation, (ii) laboratories, (iii) a system of human resources and means. Other relevant pharmacy legislation affecting availability was also reviewed and redrafted. More specifically the TA: Assessed the capacity of the laboratories capable of conduction pharmaceutical analysis; Gave recommendations on how the DRA and related quality assurance structures should operate to achieve the objective of safe medicines on the market; Make specific recommendations as how to make QA efficient and maximize its outcome; Review and propose amendments to pharmacy regulation. Where necessary new legislation will be drafted; Workshops to present results and proposed changes; Develop indicators monitoring the quality assurance of medicines.
Year:	2008

Assignment:	Diagnosis and reorganisation of the pharmaceutical sector
Client:	World Bank
Country:	Rwanda
Fields of expertise:	Drug Regulatory Authority Support, Drug Supply Management System Strengthening, Essential Drugs Programme Support, Essential Medicines Financing, Health Sector Reform, Medical Store Evaluation, National Medicines Policy Development, Pharmaceutical Sector Review, Planning, Organisation and Management, Quantification of Essential Drug Needs, Rational Use Surveys, Selection of Essential Medicines, Training and Human Resource Development
Description:	Narrative Description of Project: Diagnosis and reorganisation of the pharmaceutical sector in Rwanda (public and private sector). Development of a national policy and legislation for the pharmaceutical sector. Institutional strengthening of the Pharmaceutical Department of the Ministry of Health. Technical and organisational proposals for a new structure for a national central medical store. Quantification of the national needs for essential drugs. Development of the strategies for procurement, supply, storing and distribution of the essential drugs. Proposal for a diagnostic and treatment standard. Strategies for the registration, quality control and rational use of drugs. Development of financial policies for drugs (custom duties, price regulation, etc.). Proposal for the financing of the development plan of the pharmaceutical sector. Description of Actual Services Provided: Responsible for a detailed analysis of the pharmaceutical sector, including policy, legislation, provision and supply of drugs, drug needs by level and by sector, drug use, drug registration, drug financing aspects. Provided assistance to the Ministry of Health in all the above fields to develop proposals to reform. Assisted the Ministry of Health in developing a new central medical stores structure as a parastatal organisation. Developed a financial plan for all proposed reforms. Consensus development at a national and international workshop where proposals for reform have been presented. The actual and functional national central medical store in Kigali is based on the feasibility study and the technical proposals made by HERA-CDP.
Year:	1993 - 1994

Assignment:	Azerbaijan Health Sector Reform Project – workshop on procurement of drugs
Client:	World Bank
Country:	Azerbaijan
Fields of expertise:	Essential Drugs Programme Support, Medical Store Evaluation, National Medicines Policy Development, Procurement and Tender Support
Description:	Narrative description of Project: The objectives of this project were to present generally accepted principles and methods on: Principles of state drug provision to the population Provision of affordable drug cost and cost containment strategies Principles for determining wholesale prices State control over the prices of procured drugs vs. market liberalization: costs and benefits Principles for composing the list of drugs to be procured by state facilities The tendering system for procurement of drugs Mandatory conditions reflected in contracts for procurement of drugs. Description of actual services provided by your staff within the assignment: On request of the World Bank Lead Health Specialist for Europe and Central Asia the HERA Pharmaceutical Procurement Consultant and the World Bank Senior Procurement Specialist conducted a one-day high level seminar on pharmaceutical policies and processes in Baku, Azerbaijan. The opportunity of the consultant’s visit was used to meet with relevant authorities and some key persons in the pharmaceutical sector and review some of the available documents. The two presentations, prepared with inputs of the full HERA pharmaceutical team, focused discussions on the pharmaceutical policy and procurement and implementation of best practices taking into account other countries’ experiences as well as guidelines from international organizations such as WHO, World Bank and PIC/S (Pharmaceutical Inspection Convention - Scheme). Upon his return the consultant prepared a report with his observations and recommendations regarding Azerbaijan’s pharmaceutical sector, including discussions at the seminar and taking into account the requests from the deputy minister for more information on the methodology of a price survey and information on medicines legislation and regulations.
Year:	2009

Assignment:	Review of the Pharmaceutical Sector
Client:	World Bank - Ministry of Health
Country:	Kenya
Fields of expertise:	Drug Regulatory Authority Support, Drug Supply Management System Strengthening, Essential Drugs Programme Support, Health Policy and Policy Dialogue, Health Sector Reform, Health Sector Review or Health Sector Diagnosis, Monitoring and Evaluation, National Medicines Policy Development, Pharmaceutical Sector Review, Procurement and Tender Support, Quantification of Essential Drug Needs, Rational Use Surveys
Description:	Narrative description of Project: The Government of Kenya, with support from its partners including the World Bank, has committed itself to a series of reform efforts in the health sector. As part of this , the MOH commissioned a comprehensive review of the pharmaceutical sector. The review was contracted in 4 different consultancies of which HERA completed 3 parts: Consultancy for Evaluation of Pharmaceutical Access in Kenya, including an Institutional Capacity Assessment of the MOH and KEMSA Consultancy for Evaluating/Improving Quality Assurance and Sustainability in the Medical Supplies Sub-sector in Kenya Consultancy to strengthen the logistics Management and the Rational Use of Drugs in Kenya. Description of actual services provided: Evaluation of Pharmaceutical Access in Kenya: Description of geographical, physical and financial access to drugs in Kenya, particularly for the diseases of poverty, in both public and private sectors; Evaluation of the structure, functioning and outcomes of the existing drug supply systems (including the procurement, warehousing and distribution of drugs to all levels of the health care system); Assessment of the structure, functioning and outcomes of the existing pharmaceutical financing and pricing systems from an efficiency and equity perspective; Development of alternative proposals for efficient and equitable systems of drug supply management, financing and pricing. Evaluating/ Improving Quality Assurance and Sustainability in the Medical Supplies Sub-sector : Description and evaluation of the overall structure, process and performance of drug quality assurance/control systems at both central and provincial levels; Assessment of the procedures ensuring the quality of drugs and of manufacturing facilities, the thoroughness and frequency of these quality inspections and the overall effectiveness of the quality assurance/control systems; Detailed analysis of all the sources and uses of Drug Control Authority Funds; Development of recommendations to ensure that the systems for drug quality assurance at all levels of the health system in the public and private sectors function efficiently and effectively in the future. Strengthening the Logistics Management and Rational Use of Drugs: Description and analysis of the existing patterns of drug prescription, dispensing and consumption in the public and private sectors. Review of the logistics management system in the public and private sectors and recommendations for strengthening and developing a national procurement and logistics management action plan; Evaluation of the existing policies, norms, standards and practices related to the use of pharmaceuticals by health professionals and consumers; Development of alternative proposals for the establishment of an effective program for rational drug use (including an essential drugs policy and generics strategy).
Year:	2004 - 2005